Lipella Pharmaceuticals
LIPO
#10024
Rank
S$3.93 M
Marketcap
$3.26
Share price
-1.63%
Change (1 day)
-73.52%
Change (1 year)

P/S ratio for Lipella Pharmaceuticals (LIPO)

P/S ratio as of November 2024 (TTM): 6.51

According to Lipella Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.72. At the end of 2024 the company had a P/S ratio of 7.61.

P/S ratio history for Lipella Pharmaceuticals from 2022 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20247.61-42.19%
202313.2-86.51%
202297.6